Piper Sandler Starts CareDx at Overweight
Bullish analyst initiation with notable implied upside, but the view is based on a single analyst opinion.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Bullish analyst initiation with notable implied upside, but the view is based on a single analyst opinion.
What happened, with direct paths to the underlying reporting
Piper Sandler initiated coverage of CareDx (CDNA) with an Overweight rating and a $100 price target, about 24% above the posted price of $80.77. Analyst targets are opinions and do not guarantee performance.
Target: $100
Posted price: $80.77
Analyst firm: Piper Sandler
Analyst: David Westenberg
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.